Abstract:Introduction: Arsenic (As) exposure is associated with lung toxicity and we aim to investigate the effects of arsenic exposure on lung fibrotic changes. Methods: Participants (n= 976) enrolled via a general health survey underwent chest low-dose computed tomography (LDCT), spirometry forced expiratory volume in 1 s (FEV1), forced vital capacity (FVC), and urinary arsenic examination during 2016 and 2018. Lung fibrotic changes from LDCT were defined. As LtoL , low arsenic levels in both 2016 and 2018; As LtoH , low arsenic in 2016 but high levels in 2018; As HtoL , high arsenic in 2016 but low levels in 2018; As HtoH , high arsenic levels in both 2016 and 2018. Mice exposed to 0. 0.2mg/L, 2 mg/L, 50 mg/L of sodium arsenite (NaAsO 2 ) through drinking water for 12 weeks and 24 weeks were applied for histological analysis. Cultured lung epithelial cells were exposed to NaAsO 2 and the mesenchymal changes were examined. Results: As HtoH increased the risk (OR= 1.65, 95% CI 1.10, 2.49) of Lung fibrotic positive to positive (reference: Lung fibrotic negative to negative ) compared with As LtoL . Moreover, the predicted mean of FVC and FEV1 in As HtoH (−0.09 units, 95% CI: −0.27, −0.09; −0.09 units, 95% CI: −0.17, −0.01) and As LtoH (−0.13 units, 95% CI: −0.30, −0.10; −0.13 units, 95% CI: −0.22, −0.04) was significantly lower than AS LtoL . Significant lung fibrotic changes including the increase of the alveolar septum thickness and collagen fiber deposition were observed upon 2 mg/L NaAsO 2 treatment for 12 weeks, and the damage was dose- and time-dependent. In vitro , sodium arsenite treatment promotes the epithelial-mesenchymal transition (EMT)-like changes of the normal human bronchial epithelial cells, including upregulation of several fibrotic and mesenchymal markers (fibronectin, MMP-2, and Snail) and cell migration. Inhibition of reactive oxygen species (ROS) and MMP-2 impaired the arsenic-induced EMT changes. Administration of a flavonoid, apigenin, inhibited EMT in vitro and pulmonary damages in vivo with the reduction of mesenchymal markers. Discussion: we demonstrated that continued exposure to arsenic causes lung fibrosis in humans and mice. Targeting lung epithelial cells EMT is effective on the development of therapeutic strategy. Apigenin is effective in the inhibition of arsenic-induced pulmonary fibrosis and EMT.

Aortic smooth muscle cell alterations in mice systemically exposed to arsenic

Molecular mechanism of the increased tissue uptake of trivalent inorganic arsenic in mice with type 1 diabetes mellitus.

Chronic arsenic exposure affects stromal cells and signaling in the small intestine in a sex-specific manner

Arsenic exposure and lung fibrotic changes-evidence from a longitudinal cohort study and experimental models

Differential Effects of Arsenic in Drinking Water on Mouse Hepatic and Intestinal Heme Oxygenase-1 Expression

Cardiovascular adverse effects and mechanistic insights of arsenic exposure: a review

Effects of dietary arsenic exposure on liver metabolism in mice

Distribution of Arsenic Species and Pathological Characteristics of Tissues of the Mice Fed with Arsenic-Supplemented Food Simulating Rice.

Inorganic Arsenic Exposure Decreases Muscle Mass and Enhances Denervation-Induced Muscle Atrophy in Mice

Oral arsenite exposure induces inflammation and apoptosis in pulmonary tissue: acute and chronic evaluation in young and adult mice

Arsenic Impairs Wound Healing Processes in Dermal Fibroblasts and Mice

Arsenic induces human chondrocyte senescence and accelerates rat articular cartilage aging

Enhancement between environmental tobacco smoke and arsenic on emphysema-like lesions in mice

Long-term arsenic exposure decreases mice body weight and liver lipid droplets

Changes induced by chronic exposure to high arsenic concentrations in the intestine and its microenvironment

Analysis of arsenic-modulated expression of hypothalamic estrogen receptor, thyroid receptor, and peroxisome proliferator-activated receptor gamma mRNA and simultaneous mitochondrial morphology and respiration rates in the mouse

Clinical, Hematological and Histopathological Responses to Arsenic Toxicity in ICR Mice Using Arsenic Levels Synonymous to Buruli Ulcer EndemicCommunities in the Amansie West District of Ghana

Arsenic exposure at environmentally relevant levels induced metabolic toxicity in development mice: Mechanistic insights from integrated transcriptome and metabolome

Transcriptomic Effects of Low-Dose Inorganic Arsenic Exposure on Murine Bone Marrow-Derived Macrophages

Acute arsenic toxicity alters cytochrome P450 and soluble epoxide hydrolase and their associated arachidonic acid metabolism in C57Bl/6 mouse heart

Effects of Inorganic Arsenic on the Rat and Mouse Urinary Bladder